ASTH (Astrana Health) Change In Receivables: $0 Mil (TTM As of Mar. 2026)


ASTH Astrana Health Inc ASTH
87 GF Score
Price $47.04
GF Value $82.79
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Change In Receivables?

Astrana Health ASTH +0.28% 87 Change In Receivables is $0 Mil as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.79 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Astrana Health's change in receivables for the quarter that ended in Mar. 2026 was $0 Mil. It means Astrana Health's Accounts Receivable stayed the same from Dec. 2025 to Mar. 2026 .

Astrana Health's change in receivables for the fiscal year that ended in Dec. 2025 was $-7 Mil. It means Astrana Health's Accounts Receivable increased by $7 Mil from Dec. 2024 to Dec. 2025 .

Astrana Health's Accounts Receivable for the quarter that ended in Mar. 2026 was $467 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Astrana Health's Days Sales Outstanding for the three months ended in Mar. 2026 was 44.19.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Astrana Health's liquidation value for the three months ended in Mar. 2026 was $-952 Mil.

Astrana Health  (NAS:ASTH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Astrana Health's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=467.395/965.1*91
=44.19

2. In Ben Graham's calculation of liquidation value, Astrana Health's accounts receivable are only considered to be worth 75% of book value:

Astrana Health's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=478.383-1781.371+0.75 * 467.395+0.5 * 0
=-952

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Change In Receivables Related Terms

Astrana Health Change In Receivables Historical Data

* Premium members only.

The historical data trend for Astrana Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Change In Receivables Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.99 -25.77 -20.26 -11.10 -7.16

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.76 0.00 0.00 0.00 0.00
ASTH
87GF Score
Astrana Health Inc ASTH
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0 Mil mean?
Astrana Health (ASTH) has a Change In Receivables of $0 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Astrana Health and its competitors.
Is Astrana Health's Change In Receivables too high?
Astrana Health's current Change In Receivables is $0 Mil. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Change In Receivables compare to SGRY and SEM?
Astrana Health's Change In Receivables of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Astrana Health and its competitors. Astrana Health's current Change In Receivables is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.79, compared to a current price of $47.04 — trading 43.2% below its estimated fair value. The current Change In Receivables is $0 Mil. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Astrana Health (ASTH), the current Change In Receivables is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $47.04 is trading 43.2% below its estimated GF Value™ of $82.79. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Change In Receivables: $0 Mil
  • GF Value™: $82.79 vs. price of $47.04 (43.2% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$47.04
Price
$82.79
GF Value